Ralf Dujardin - Imaflex Vice President - Marketing and Innovation

IFLXF Stock  USD 1.00  0.00  0.00%   

President

Dr. Ralf Dujardin, Ph.D., is Vice President Marketing and Innovation of Imaflex Inc., with effect from July 1, 2013. Dr. Dujardin joins Imaflex after spending 26 years within the Bayer organization. Dr. Dujardin started his career with Bayer in 1986 as a polymer chemist. He was most recently Portfolio Manager and Senior Project Manager at Bayer Innovation GmbH in Germany. In this role, he was responsible for strategically building a portfolio of innovative products and intellectual property, which included active ingredient equipped plastics for the agriculture market. Prior to this role, Dr. Dujardin was Vice President Corporationrationrate Venturing and Business Development, where he managed a fund of approximately 25 million in selected material and life science investments since 2013.
Tenure 12 years
Professional MarksPh.D
Phone514 935 5710
Webhttps://www.imaflex.com
Dujardin completed his PhD in Chemistry at the University of Siegen in Germany in 1986.

Imaflex Management Efficiency

The company has return on total asset (ROA) of 0.0981 % which means that it generated a profit of $0.0981 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.209 %, meaning that it generated $0.209 on every $100 dollars invested by stockholders. Imaflex's management efficiency ratios could be used to measure how well Imaflex manages its routine affairs as well as how well it operates its assets and liabilities.
Imaflex has accumulated 3.5 M in total debt with debt to equity ratio (D/E) of 0.18, which may suggest the company is not taking enough advantage from borrowing. Imaflex has a current ratio of 2.44, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Imaflex until it has trouble settling it off, either with new capital or with free cash flow. So, Imaflex's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Imaflex sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Imaflex to invest in growth at high rates of return. When we think about Imaflex's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

MBA MAAmcor PLC
65
Lori BondarAvery Dennison Corp
63
Lauren TashmaGraphic Packaging Holding
59
Deon StanderAvery Dennison Corp
56
Joseph YostGraphic Packaging Holding
58
Hilde MoesekeGraphic Packaging Holding
48
Kimberly UlmerSilgan Holdings
57
Michael CasamentoAmcor PLC
49
BApSc MBADSS Inc
45
Stacey PanayiotouGraphic Packaging Holding
48
Frederick StephanAmcor PLC
60
Jay MartinSilgan Holdings
51
Thomas SnyderSilgan Holdings
58
Francisco MeloAvery Dennison Corp
51
Susan MillerAvery Dennison Corp
60
Nicholas ColistoAvery Dennison Corp
58
Thomas CochranAmcor PLC
62
Michael FarrellGraphic Packaging Holding
56
Ryan YostAvery Dennison Corp
N/A
Gregory LovinsAvery Dennison Corp
52
Michael ZackaAmcor PLC
58
Imaflex Inc., together with its subsidiaries, develops, manufactures, and sells flexible packaging materials for industrial and agriculture markets in Canada, the United States, and internationally. The company was founded in 1994 and is headquartered in Montreal, Canada. Imaflex operates under Packaging Containers classification in the United States and is traded on OTC Exchange. It employs 221 people. Imaflex [IFLXF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Imaflex Leadership Team

Elected by the shareholders, the Imaflex's board of directors comprises two types of representatives: Imaflex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Imaflex. The board's role is to monitor Imaflex's management team and ensure that shareholders' interests are well served. Imaflex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Imaflex's outside directors are responsible for providing unbiased perspectives on the board's policies.
Joseph Abbandonato, Chairman of the Board and Presidentident, CEO
John Ripplinger, Vice President - Corporate Affairs
Tony Abbandonato, Vice President Corporate Secretary
Ralf Dujardin, Vice President - Marketing and Innovation

Imaflex Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Imaflex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Imaflex Pink Sheet

Imaflex financial ratios help investors to determine whether Imaflex Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Imaflex with respect to the benefits of owning Imaflex security.